Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03408587
Title CAVATAK and Ipilimumab in Uveal Melanoma Metastatic to the LIver (VLA-024 CLEVER) (CLEVER)
Acronym CLEVER
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Viralytics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.